RELIEF THERAPEUTICS
Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Its lead drug candidate RLF-100TM (aviptadil) is being investigated in two placebo-controlled U.S. late-stage clinical trials in respiratory deficiency due to COVID-19. Relief holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM.
RELIEF THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2013-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.relieftherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
29.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Office 365 Mail IPv6
Similar Organizations
Amarna Therapeutics
Amarna Therapeutics is a privately held European biotechnology company.
Biotherapeutics
BioTherapeutics Inc. (BTI) is a pre-clinical stage company
Cinclus Pharma
Cinclus Pharma is a research based biotech company.
DataMatrix
DataMatrix is a software that helps its users in organizing and managing clinical research.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Indivumed GmbH
A Hamburg,Germany-based physician-led, integrated global oncology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Mablink Bioscience
Mablink Bioscience is a biotechnology company.
MaxiVAX
MaxiVAX is a Swiss clinical-stage biotechnology company.
Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals is a clinical-stage ophthalmology drug development company.
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
NovaBiotics
NovaBiotics Ltd is a clinical-stage biotechnology company.
RetiPharma
RetiPharma is a Danish Biotech company
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on emerging infectious diseases and a a majority woman owned business
SpheroTec GmbH
SpheroTec GmbH is a biotech company using 3D cell-culture systems.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-28 | AdVita Lifescience | AdVita Lifescience acquired by Relief Therapeutics | N/A |
| 2021-06-29 | APR Applied Pharma Research | APR Applied Pharma Research acquired by Relief Therapeutics | 66.5 M CHF |
| 2016-07-27 | FirstString Research | FirstString Research acquired by Relief Therapeutics | N/A |
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Series A - Relief Therapeutics
Key Employee Changes
Official Site Inspections
http://www.relieftherapeutics.com Semrush global rank: 227.84 K Semrush visits lastest month: 317.56 K
- Host name: h2web45.infomaniak.ch
- IP address: 128.65.195.91
- Location: Satigny Switzerland
- Latitude: 46.2146
- Longitude: 6.0355
- Timezone: Europe/Zurich
- Postal: 1242
More informations about "Relief Therapeutics"
Company
Relief Therapeutics is a Swiss, commercial - stage biopharmaceutical company, developing and commercializing novel, patent-protected products in selected specialty, rare and ultra-rare …See details»
Relief Therapeutics
Relief Therapeutics is a Swiss, commercial - stage biopharmaceutical company, developing and commercializing novel, patent-protected products in selected specialty, rare and ultra-rare diseases.See details»
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied …
GENEVA (NOV. 22, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering …See details»
Relief Therapeutics - Wikipedia
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in …See details»
Relief Therapeutics SA - Swiss Biotech
Relief Therapeutics Holding AG (SIX: RLF) is a Swiss-based publicly-traded drug development company focusing primarily on the clinical development of peptides and proteins of natural or engineered origin to address unmet medical needs. …See details»
Relief Therapeutics - Crunchbase Company Profile & Funding
Relief Therapeutics is a clinical stage biotechnology company. View contacts for Relief Therapeutics to access new leads and connect with decision-makers.See details»
RELIEF THERAPEUTICS Holding - Overview, News & Similar
View RELIEF THERAPEUTICS Holding (www.relieftherapeutics.com) location in Geneva, Switzerland , revenue, industry and description. Find related and similar companies as well as …See details»
Relief Therapeutics Announces Swissmedic Approval and …
May 15, 2023 · Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety and …See details»
Relief Therapeutics - VentureRadar
Website: https://relieftherapeutics.com/ Develops and commercializes novel, patent-protected biopharmaceutical products for metabolic, dermatological, and pulmonary rare diseases, with …See details»
Relief Therapeutics Shifts Commercial Operations to Partnership …
Dec 5, 2023 · Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety, and …See details»
Relief Therapeutics Announces CEO Transition - Yahoo Finance
Nov 22, 2023 · Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety, and …See details»
Relief Therapeutics Announces Transitions in Commercial …
Relief Therapeutics Announces Transitions in Commercial Organization to Implement Next Phase of Corporate Development • Anthony M. Kim Appointed Senior Vice President and Head of …See details»
Relief Therapeutics Announces Full Year 2022 Financial Results and ...
Apr 14, 2023 · We made substantial progress in our transformation of Relief Therapeutics into a fully integrated, commercial-stage biopharmaceutical company in 2022, strengthening our …See details»
Relief Therapeutics Reports Half-Year 2024 Financial Results and ...
Aug 30, 2024 · Relief is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety, and convenience to …See details»
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied …
Dec 8, 2022 · Relief is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of novel, patent protected products intended …See details»
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc.
Dec 20, 2022 · RELIEF THERAPEUTICS Holding SA is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of …See details»
Relief Therapeutics Announces Full Year 2022 Financial Results and ...
Apr 14, 2023 · We maintain a lean organization, with a strong, experienced leadership team that has the proven ability to execute our disciplined, cost-effective, capital-efficient approach to …See details»
Relief Therapeutics Renews CHF 50 million Share Subscription …
Feb 28, 2024 · Relief and GEM have agreed to renew the SSF agreement for an additional three-year period. Under the terms of the agreement, Relief has the right to periodically issue and …See details»
RELIEF THERAPEUTICS Holding SA (RLF) Stock Price & News
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its …See details»
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied …
Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional PatentsSee details»